CD276 and cancer: B7‐H3 can promote tumor angiogenesis and reduce the sensitivity of metastatic tumors to therapeutic drugs, pointing to an adverse effect on the prognosis of patients, and is therefore an important indicator in predicting cancer progression [13, 39].